HomeCompareTFLT vs JNJ

TFLT vs JNJ: Dividend Comparison 2026

TFLT yields 8.60% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TFLT wins by $15.3K in total portfolio value
10 years
TFLT
TFLT
● Live price
8.60%
Share price
$23.27
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$35.3K
Annual income
$1,479.44
Full TFLT calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — TFLT vs JNJ

📍 TFLT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTFLTJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TFLT + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TFLT pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TFLT
Annual income on $10K today (after 15% tax)
$730.71/yr
After 10yr DRIP, annual income (after tax)
$1,257.52/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, TFLT beats the other by $553.91/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TFLT + JNJ for your $10,000?

TFLT: 50%JNJ: 50%
100% JNJ50/50100% TFLT
Portfolio after 10yr
$27.7K
Annual income
$1,153.61/yr
Blended yield
4.17%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

TFLT
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TFLT buys
0
JNJ buys
0
No recent congressional trades found for TFLT or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTFLTJNJ
Forward yield8.60%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$35.3K$20.0K
Annual income after 10y$1,479.44$827.78
Total dividends collected$11.7K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TFLT vs JNJ ($10,000, DRIP)

YearTFLT PortfolioTFLT Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,560$859.66$10,676$355.77+$884.00TFLT
2$13,298$928.73$11,407$389.39+$1.9KTFLT
3$15,227$998.46$12,198$426.53+$3.0KTFLT
4$17,361$1,068.53$13,056$467.62+$4.3KTFLT
5$19,715$1,138.61$13,987$513.12+$5.7KTFLT
6$22,304$1,208.39$14,998$563.56+$7.3KTFLT
7$25,142$1,277.61$16,098$619.52+$9.0KTFLT
8$28,248$1,346.01$17,295$681.69+$11.0KTFLT
9$31,639$1,413.36$18,599$750.82+$13.0KTFLT
10$35,333$1,479.44$20,022$827.78+$15.3KTFLT

TFLT vs JNJ: Complete Analysis 2026

TFLTStock

The investment seeks investment results that correspond to the price and yield performance, before fees and expenses, of the Wilshire TargetIncomeTM 10-Year Treasury +2% Plus Index. The fund is a fund of funds and invests at least 80% of its total assets in the securities of the underlying index. The underlying index seeks to provide broad exposure to income-producing asset classes using a portfolio of exchange-traded funds, with the goal, but not the guarantee, of providing exposure that may be sufficient to support an annualized yield of the U.S. 10-Year Treasury yield plus two percent for the fund, net of fees. The fund is non-diversified.

Full TFLT Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this TFLT vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TFLT vs SCHDTFLT vs JEPITFLT vs OTFLT vs KOTFLT vs MAINTFLT vs ABBVTFLT vs MRKTFLT vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.